AJCN North Carolina Research Campus
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pancharuniti, N.
Right arrow Articles by Cousins, A. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pancharuniti, N.
Right arrow Articles by Cousins, A. L.
Agricola
Right arrow Articles by Pancharuniti, N.
Right arrow Articles by Cousins, A. L.

American Journal of Clinical Nutrition, Vol 59, 940-948, Copyright © 1994 by The American Society for Clinical Nutrition, Inc


ORIGINAL RESEARCH COMMUNICATIONS

Plasma homocyst(e)ine, folate, and vitamin B-12 concentrations and risk for early-onset coronary artery disease [published erratum appears in Am J Clin Nutr 1996 Apr;63(4):609]

N Pancharuniti, CA Lewis, HE Sauberlich, LL Perkins, RC Go, JO Alvarez, M Macaluso, RT Acton, RB Copeland and AL Cousins
Department of Epidemiology, School of Public Health, University of Alabama at Birmingham 35294-0008.

High plasma homocyst(e)ine (Hcy) concentrations may be a determinant of coronary artery disease (CAD). Folate and vitamin B-12 are required for the primary metabolic pathway to reduce Hcy concentrations. The interrelationships of Hcy and these two vitamin cofactors were investigated in a case-control study of 101 white males aged 30-50 y with angiographically demonstrated CAD, and 108 white male, similarly aged, control subjects living in the same community as the patients. The odds ratio (OR) of CAD per quartile increase of plasma Hcy concentration based on control values was 1.6 (95% CI: 1.3, 2.1). After age, HDL and LDL cholesterol, body mass index, smoking, hypertension, and diabetes were controlled for, Hcy remained an independent risk factor (OR: 1.4; 95% CI: 1.0, 2.0). The OR change per quartile increase of folate concentration was 0.8 (95% CI: 0.6, 1.0). This difference was reduced (OR: 0.9; 95% CI: 0.7, 1.2) after Hcy adjustment. No difference in the geometric mean of vitamin B-12 concentration was found between patients and control subjects, both 5.8 nmol/L. However, after Hcy and the other CAD risk factors were controlled for, the OR per quartile increase in vitamin B-12 concentration was 1.5 (95% CI: 1.0, 1.8). Reduction in plasma Hcy by interventions to increase plasma folate concentration may decrease CAD risk.


This article has been cited by other articles:


Home page
Eur Heart JHome page
D. Vanuzzo, L. Pilotto, R. Lombardi, G. Lazzerini, M. Carluccio, S. Diviacco, F. Quadrifoglio, G. Danek, D. Gregori, P. Fioretti, et al.
Both vitamin B6 and total homocysteine plasma levels predict long-term atherothrombotic events in healthy subjects
Eur. Heart J., February 2, 2007; 28(4): 484 - 491.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
V. Ganji and M. R Kafai
Population reference values for plasma total homocysteine concentrations in US adults after the fortification of cereals with folic acid.
Am. J. Clinical Nutrition, November 1, 2006; 84(5): 989 - 994.
[Abstract] [Full Text] [PDF]


Home page
J. Gerontol. A Biol. Sci. Med. Sci.Home page
H.-K. Kuo, F. A. Sorond, J.-H. Chen, A. Hashmi, W. P. Milberg, and L. A. Lipsitz
The Role of Homocysteine in Multisystem Age-Related Problems: A Systematic Review
J. Gerontol. A Biol. Sci. Med. Sci., September 1, 2005; 60(9): 1190 - 1201.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
V. Ganji and M. R. Kafai
Population References for Plasma Total Homocysteine Concentrations for U.S. Children and Adolescents in the Post-Folic Acid Fortification Era
J. Nutr., September 1, 2005; 135(9): 2253 - 2256.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
V. Ganji and M. R Kafai
Frequent consumption of milk, yogurt, cold breakfast cereals, peppers, and cruciferous vegetables and intakes of dietary folate and riboflavin but not vitamins B-12 and B-6 are inversely associated with serum total homocysteine concentrations in the US population
Am. J. Clinical Nutrition, December 1, 2004; 80(6): 1500 - 1507.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. Chandalia, N. Abate, A. V. Cabo-Chan Jr., S. Devaraj, I. Jialal, and S. M. Grundy
Hyperhomocysteinemia in Asian Indians Living in the United States
J. Clin. Endocrinol. Metab., March 1, 2003; 88(3): 1089 - 1095.
[Abstract] [Full Text] [PDF]


Home page
MutagenesisHome page
X. Wang and M. Fenech
A comparison of folic acid and 5-methyltetrahydrofolate for prevention of DNA damage and cell death in human lymphocytes in vitro
Mutagenesis, January 1, 2003; 18(1): 81 - 86.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
U. Lim and P. A. Cassano
Homocysteine and Blood Pressure in the Third National Health and Nutrition Examination Survey, 1988-1994
Am. J. Epidemiol., December 15, 2002; 156(12): 1105 - 1113.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
Homocysteine Studies Collaboration
Homocysteine and Risk of Ischemic Heart Disease and Stroke: A Meta-analysis
JAMA, October 23, 2002; 288(16): 2015 - 2022.
[Abstract] [Full Text] [PDF]


Home page
Vasc MedHome page
N. Weiss, C. Keller, U. Hoffmann, and J. Loscalzo
Endothelial dysfunction and atherothrombosis in mild hyperhomocysteinemia
Vascular Medicine, August 1, 2002; 7(3): 227 - 239.
[Abstract] [PDF]


Home page
J. Nutr.Home page
J. Bryan, E. Calvaresi, and D. Hughes
Short-Term Folate, Vitamin B-12 or Vitamin B-6 Supplementation Slightly Affects Memory Performance But Not Mood in Women of Various Ages
J. Nutr., June 1, 2002; 132(6): 1345 - 1356.
[Abstract] [Full Text] [PDF]


Home page
Int J EpidemiolHome page
E. S Ford, S J. Smith, D. F Stroup, K. K Steinberg, P. W Mueller, and S. B Thacker
Homocyst(e)ine and cardiovascular disease: a systematic review of the evidence with special emphasis on case-control studies and nested case-control studies
Int. J. Epidemiol., February 1, 2002; 31(1): 59 - 70.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M.C. Verhaar, E. Stroes, and T.J. Rabelink
Folates and Cardiovascular Disease
Arterioscler. Thromb. Vasc. Biol., January 1, 2002; 22(1): 6 - 13.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
P. Madonna, V. de Stefano, A. Coppola, F. Cirillo, A. M. Cerbone, G. Orefice, and G. Di Minno
Hyperhomocysteinemia and Other Inherited Prothrombotic Conditions in Young Adults With a History of Ischemic Stroke
Stroke, January 1, 2002; 33(1): 51 - 56.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
N. Matsuyama, M. Yamaguchi, M. Toyosato, M. Takayama, and K. Mizuno
New Enzymatic Colorimetric Assay for Total Homocysteine
Clin. Chem., December 1, 2001; 47(12): 2155 - 2156.
[Full Text] [PDF]


Home page
J. Gerontol. B Psychol. Sci. Soc. Sci.Home page
E. Calvaresi and J. Bryan
B Vitamins, Cognition, and Aging: A Review
J. Gerontol. B. Psychol. Sci. Soc. Sci., November 1, 2001; 56(6): P327 - 339.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
K. G Rowley, Q. Su, M. Cincotta, M. Skinner, K. Skinner, B. Pindan, G. A White, and K. O'Dea
Improvements in circulating cholesterol, antioxidants, and homocysteine after dietary intervention in an Australian Aboriginal community
Am. J. Clinical Nutrition, October 1, 2001; 74(4): 442 - 448.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
J. A. Tice, E. Ross, P. G. Coxson, I. Rosenberg, M. C. Weinstein, M. G. M. Hunink, P. A. Goldman, L. Williams, and L. Goldman
Cost-effectiveness of Vitamin Therapy to Lower Plasma Homocysteine Levels for the Prevention of Coronary Heart Disease: Effect of Grain Fortification and Beyond
JAMA, August 22, 2001; 286(8): 936 - 943.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
K. K. A. Witte, A. L. Clark, and J. G. F. Cleland
Chronic heart failure and micronutrients
J. Am. Coll. Cardiol., June 1, 2001; 37(7): 1765 - 1774.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
G. Liaugaudas, P. F. Jacques, J. Selhub, I. H. Rosenberg, and A. G. Bostom
Renal Insufficiency, Vitamin B12 Status, and Population Attributable Risk for Mild Hyperhomocysteinemia Among Coronary Artery Disease Patients in the Era of Folic Acid-Fortified Cereal Grain Flour
Arterioscler. Thromb. Vasc. Biol., May 1, 2001; 21(5): 849 - 851.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
K. M Koehler, R. N Baumgartner, P. J Garry, R. H Allen, S. P Stabler, and E. B Rimm
Association of folate intake and serum homocysteine in elderly persons according to vitamin supplementation and alcohol use
Am. J. Clinical Nutrition, March 1, 2001; 73(3): 628 - 637.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
S.-M. Saw, J.-M. Yuan, C.-N. Ong, K. Arakawa, H.-P. Lee, G. A Coetzee, and M. C Yu
Genetic, dietary, and other lifestyle determinants of plasma homocysteine concentrations in middle-aged and older Chinese men and women in Singapore
Am. J. Clinical Nutrition, February 1, 2001; 73(2): 232 - 239.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
Y. Jang, J. H. Lee, E. Y. Cho, N. S. Chung, D. Topham, and B. Balderston
Differences in body fat distribution and antioxidant status in Korean men with cardiovascular disease with or without diabetes
Am. J. Clinical Nutrition, January 1, 2001; 73(1): 68 - 74.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
R. M. Krauss, R. H. Eckel, B. Howard, L. J. Appel, S. R. Daniels, R. J. Deckelbaum, J. W. Erdman Jr, P. Kris-Etherton, I. J. Goldberg, T. A. Kotchen, et al.
AHA Scientific Statement: AHA Dietary Guidelines: Revision 2000: A Statement for Healthcare Professionals From the Nutrition Committee of the American Heart Association
J. Nutr., January 1, 2001; 131(1): 132 - 146.
[Full Text]


Home page
Arch Intern MedHome page
C. M. Loria, D. D. Ingram, J. J. Feldman, J. D. Wright, and J. H. Madans
Serum Folate and Cardiovascular Disease Mortality Among US Men and Women
Arch Intern Med, November 27, 2000; 160(21): 3258 - 3262.
[Abstract] [Full Text] [PDF]


Home page
ANGIOLOGYHome page
R. M. Fleming and L. B. Boyd
The Effect of High-Protein Diets on Coronary Blood Flow
Angiology, October 1, 2000; 51(10): 817 - 826.
[Abstract] [PDF]


Home page
Am. J. Clin. Nutr.Home page
L. Brattstrom and D. E. Wilcken
Homocysteine and cardiovascular disease: cause or effect?
Am. J. Clinical Nutrition, August 1, 2000; 72(2): 315 - 323.
[Abstract] [Full Text] [PDF]


Home page
CMAJHome page
G. L. Booth, E. E.L. Wang, and with the Canadian Task Force on Preventive Health
Preventive health care, 2000 update: screening and management of hyperhomocysteinemia for the prevention of coronary artery disease events
Can. Med. Assoc. J., July 1, 2000; 163(1): 21 - 29.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
L. J Riddell, A. Chisholm, S. Williams, and J. I Mann
Dietary strategies for lowering homocysteine concentrations
Am. J. Clinical Nutrition, June 1, 2000; 71(6): 1448 - 1454.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
W. G. Christen, U. A. Ajani, R. J. Glynn, and C. H. Hennekens
Blood Levels of Homocysteine and Increased Risks of Cardiovascular Disease: Causal or Casual?
Arch Intern Med, February 28, 2000; 160(4): 422 - 434.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
H. H. Yu, R. Joubran, M. Asmi, T. Law, A. Spencer, M. Jouma, and N. Rifai
Agreement among Four Homocysteine Assays and Results in Patients with Coronary Atherosclerosis and Controls
Clin. Chem., February 1, 2000; 46(2): 258 - 264.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
K. ROBINSON
Homocysteine, B vitamins, and risk of cardiovascular disease
Heart, February 1, 2000; 83(2): 127 - 130.
[Full Text]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
H. W. Wilmink, E. S. G. Stroes, W. D. Erkelens, W. B. Gerritsen, R. Wever, J.-D. Banga, and T. J. Rabelink
Influence of Folic Acid on Postprandial Endothelial Dysfunction
Arterioscler. Thromb. Vasc. Biol., January 1, 2000; 20(1): 185 - 188.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
A. Chait, M R. Malinow, D. N Nevin, C. D Morris, R. L Eastgard, P. Kris-Etherton, F X. Pi-Sunyer, S. Oparil, L. M Resnick, J. S Stern, et al.
Increased dietary micronutrients decrease serum homocysteine concentrations in patients at high risk of cardiovascular disease
Am. J. Clinical Nutrition, November 1, 1999; 70(5): 881 - 887.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
P H Whincup, H Refsum, I J Perry, R Morris, M Walker, L Lennon, A Thomson, P M Ueland, and S B J Ebrahim
Serum total homocysteine and coronary heart disease: prospective study in middle aged men
Heart, October 1, 1999; 82(4): 448 - 454.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
A. G. Bostom, L. Bausserman, P. F. Jacques, G. Liaugaudas, J. Selhub, and I. H. Rosenberg
Cystatin C as a Determinant of Fasting Plasma Total Homocysteine Levels in Coronary Artery Disease Patients With Normal Serum Creatinine
Arterioscler. Thromb. Vasc. Biol., September 1, 1999; 19(9): 2241 - 2244.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
S L Tokgözoglu, M Alikasifoglu, I Ünsal, E Atalar, K Aytemir, N Özer, K Övünç, O Usal, S Kes, and E Tunçbilek
Methylene tetrahydrofolate reductase genotype and the risk and extent of coronary artery disease in a population with low plasma folate
Heart, May 1, 1999; 81(5): 518 - 522.
[Abstract] [Full Text]


Home page
JAMAHome page
S. K. Osganian, M. J. Stampfer, D. Spiegelman, E. Rimm, J. A. Cutler, H. A. Feldman, D. H. Montgomery, L. S. Webber, L. A. Lytle, L. Bausserman, et al.
Distribution of and Factors Associated With Serum Homocysteine Levels in Children: Child and Adolescent Trial for Cardiovascular Health
JAMA, April 7, 1999; 281(13): 1189 - 1196.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
R. Z Stolzenberg-Solomon, E. R Miller III, M. G Maguire, J. Selhub, and L. J Appel
Association of dietary protein intake and coffee consumption with serum homocysteine concentrations in an older population
Am. J. Clinical Nutrition, March 1, 1999; 69(3): 467 - 475.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
I. A Brouwer, M. van Dusseldorp, C. M. Thomas, M. Duran, J. G. Hautvast, T. K. Eskes, and R. P. Steegers-Theunissen
Low-dose folic acid supplementation decreases plasma homocysteine concentrations: a randomized trial
Am. J. Clinical Nutrition, January 1, 1999; 69(1): 99 - 104.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
W. H. Giles, J. B. Croft, K. J. Greenlund, E. S. Ford, and S. J. Kittner
Total Homocyst(e)ine Concentration and the Likelihood of Nonfatal Stroke : Results From the Third National Health and Nutrition Examination Survey, 1988–1994
Stroke, December 1, 1998; 29(12): 2473 - 2477.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Coll. Nutr.Home page
P. W. Siri, P. Verhoef, and F. J. Kok
Vitamins B6, B12, and Folate: Association with Plasma Total Homocysteine and Risk of Coronary Atherosclerosis
J. Am. Coll. Nutr., October 1, 1998; 17(5): 435 - 441.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
H. Morita, H. Kurihara, S.-i. Tsubaki, T. Sugiyama, C. Hamada, Y. Kurihara, T. Shindo, Y. Oh-hashi, K. Kitamura, and Y. Yazaki
Methylenetetrahydrofolate Reductase Gene Polymorphism and Ischemic Stroke in Japanese
Arterioscler. Thromb. Vasc. Biol., September 1, 1998; 18(9): 1465 - 1469.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
D. W. Jacobsen
Homocysteine and vitamins in cardiovascular disease
Clin. Chem., August 1, 1998; 44(8): 1833 - 1843.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
J. H. Stein and P. E. McBride
Hyperhomocysteinemia and Atherosclerotic Vascular Disease: Pathophysiology, Screening, and Treatment
Arch Intern Med, June 22, 1998; 158(12): 1301 - 1306.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
N. J. Wald, H. C. Watt, M. R. Law, D. G. Weir, J. McPartlin, and J. M. Scott
Homocysteine and Ischemic Heart Disease: Results of a Prospective Study With Implications Regarding Prevention
Arch Intern Med, April 27, 1998; 158(8): 862 - 867.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
G. N. Welch and J. Loscalzo
Homocysteine and Atherothrombosis
N. Engl. J. Med., April 9, 1998; 338(15): 1042 - 1050.
[Full Text] [PDF]


Home page
CirculationHome page
K. Robinson, K. Arheart, H. Refsum, L. Brattstrom, G. Boers, P. Ueland, P. Rubba, R. Palma-Reis, R. Meleady, L. Daly, et al.
Low Circulating Folate and Vitamin B6 Concentrations : Risk Factors for Stroke, Peripheral Vascular Disease, and Coronary Artery Disease
Circulation, February 10, 1998; 97(5): 437 - 443.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
E. B. Rimm, W. C. Willett, F. B. Hu, L. Sampson, G. A. Colditz, J. E. Manson, C. Hennekens, and M. J. Stampfer
Folate and Vitamin B6 From Diet and Supplements in Relation to Risk of Coronary Heart Disease Among Women
JAMA, February 4, 1998; 279(5): 359 - 364.
[Abstract] [Full Text] [PDF]


Home page
CLIN APPL THROMB HEMOSTHome page
K. Kottke-Marchant, R. Green, D. W. Jacobsen, A. Gupta, S. R. Savon, M. Secic, and K. Robinson
High Plasma Homocysteine: A Risk Factor for Arterial and Venous Thrombosis in Patients with Normal Coagulation Profiles
Clinical and Applied Thrombosis/Hemostasis, October 1, 1997; 3(4): 239 - 244.
[Abstract] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
P. Durand, M. Prost, and D. Blache
Folic Acid Deficiency Enhances Oral Contraceptive-Induced Platelet Hyperactivity
Arterioscler. Thromb. Vasc. Biol., October 1, 1997; 17(10): 1939 - 1946.
[Abstract] [Full Text]


Home page
NEJMHome page
O. Nygard, J. E. Nordrehaug, H. Refsum, P. M. Ueland, M. Farstad, and S. E. Vollset
Plasma Homocysteine Levels and Mortality in Patients with Coronary Artery Disease
N. Engl. J. Med., July 24, 1997; 337(4): 230 - 237.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
S. M. Schwartz, D. S. Siscovick, M. R. Malinow, F. R. Rosendaal, R. K. Beverly, D. L. Hess, B. M. Psaty, W. T. Longstreth Jr, T. D. Koepsell, T. E. Raghunathan, et al.
Myocardial Infarction in Young Women in Relation to Plasma Total Homocysteine, Folate, and a Common Variant in the Methylenetetrahydrofolate Reductase Gene
Circulation, July 15, 1997; 96(2): 412 - 417.
[Abstract] [Full Text]


Home page
BloodHome page
A. D'Angelo and J. Selhub
Homocysteine and Thrombotic Disease
Blood, July 1, 1997; 90(1): 1 - 11.
[Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
P. Verhoef, F. J. Kok, D. A.C.M. Kruyssen, E. G. Schouten, J. C.M. Witteman, D. E. Grobbee, P. M. Ueland, and H. Refsum
Plasma Total Homocysteine, B Vitamins, and Risk of Coronary Atherosclerosis
Arterioscler. Thromb. Vasc. Biol., May 1, 1997; 17(5): 989 - 995.
[Abstract] [Full Text]


Home page
CirculationHome page
H. Morita, J.-i. Taguchi, H. Kurihara, M. Kitaoka, H. Kaneda, Y. Kurihara, K. Maemura, T. Minamino, M. Ohno, K. Yamaoki, et al.
Genetic Polymorphism of 5,10-Methylenetetrahydrofolate Reductase (MTHFR) as a Risk Factor for Coronary Artery Disease
Circulation, April 15, 1997; 95(8): 2032 - 2036.
[Abstract] [Full Text]


Home page
BMJHome page
I. Graham and R. Meleady
Heart attacks and homocysteine
BMJ, December 7, 1996; 313(7070): 1419 - 1420.
[Full Text]


Home page
CirculationHome page
P. M. Gallagher, R. Meleady, D. C. Shields, K. S. Tan, D. McMaster, R. Rozen, A. Evans, I. M. Graham, and A. S. Whitehead
Homocysteine and Risk of Premature Coronary Heart Disease: Evidence for a Common Gene Mutation
Circulation, November 1, 1996; 94(9): 2154 - 2158.
[Abstract] [Full Text]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
F. M.T. Loehrer, C. P. Angst, W. E. Haefeli, P. P. Jordan, R. Ritz, and B. Fowler
Low Whole-Blood S-Adenosylmethionine and Correlation Between 5-Methyltetrahydrofolate and Homocysteine in Coronary Artery Disease
Arterioscler. Thromb. Vasc. Biol., June 1, 1996; 16(6): 727 - 733.
[Abstract] [Full Text]


Home page
CirculationHome page
K. Robinson, E. L. Mayer, D. P. Miller, R. Green, F. van Lente, A. Gupta, K. Kottke-Marchant, S. R. Savon, J. Selhub, S. E. Nissen, et al.
Hyperhomocysteinemia and Low Pyridoxal Phosphate : Common and Independent Reversible Risk Factors for Coronary Artery Disease
Circulation, November 15, 1995; 92(10): 2825 - 2830.